Please assess the completion status of the following clinical trial:

Trial Title: Effects of LDX on Functioning of College Students With ADHD

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnostic Statistical Manual of Mental Disorders 4th edition-text revision (DSM-IV-TR) criteria for ADHD based on self- and parent-report using questionnaires and clinical interview~Exclusion Criteria:~* significant cardiac condition based on medical history and/or physical examination~* significant substance abuse based on self-report and toxicology screen at intake~* significant symptoms of major depressive disorder, bipolar disorder, or thought disorder based on initial diagnostic interview

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 28 Years
- Healthy Volunteers: f

Study Arms:
- lisdexamfetamine dimesylate (Type: EXPERIMENTAL): All participants will be assessed across five conditions (baseline, placebo, 30-mg, 50-mg, \& 70-mg) in a double-blind, crossover design

Based on this trial design, predict the completion outcome and termination type (if applicable).